Coala-Life Group AB (publ)LSE Coala-Life Group Stock Report

Coala Life Group AB engages in the research and development of electromedical equipment. The company is headquartered in Stockholm, Stockholm. The company went IPO on 2001-06-26. The firm's technology automatically detect atrial fibrillation and some of the common arrhythmias, with direct feedback to the patient and care. Coala-Life Group is active in smartphone and cloud-based cardiac and pulmonary diagnostics. The head office is based in Sweden and the Company's subsidiary, Coala Life Inc, based in California, is responsible for the United States market. Development takes place mainly through a separate development department and manufacturing takes place through partners in Finland and Estonia.